{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017283","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.398111+00:00","generated_at":"2026-05-18T10:32:02.065437+00:00","sec_items":["1.01","2.03","3.02","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Indaptus raises additional $3.4M via convertible notes and warrants, total $5.7M","bullets":["Second closing of private placement adds $3.4M in convertible notes; aggregate gross proceeds now $5.7M.","Notes bear 6% interest, mature July 28, 2026; convert at 80% of 5-day VWAP (max $11.20).","Warrants for 200% of conversion shares, 5-year term, exercise price equal to the conversion price.","Net proceeds to fund Phase 1b/2 clinical trial, R&D, and working capital.","Paulson Investment Company served as exclusive placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017283","json":"https://secwatch.observer/filing/0001641172-25-017283.json","markdown":"https://secwatch.observer/filing/0001641172-25-017283.md","text":"https://secwatch.observer/filing/0001641172-25-017283.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225017283/0001641172-25-017283-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225017283/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T10:32:02.065437+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}